Integra LifeSciences Holdings Corporation
IART · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $1,100 | $938 | $1,681 | $1,747 |
| - Cash | $232 | $218 | $239 | $246 |
| + Debt | $214 | $2,014 | $2,019 | $1,985 |
| Enterprise Value | $1,081 | $2,734 | $3,461 | $3,485 |
| Revenue | $402 | $416 | $383 | $443 |
| % Growth | -3.3% | 8.6% | -13.6% | – |
| Gross Profit | $226 | $209 | $194 | $249 |
| % Margin | 56.2% | 50.4% | 50.8% | 56.3% |
| EBITDA | $54 | -$472 | $26 | $79 |
| % Margin | 13.4% | -113.6% | 6.8% | 17.9% |
| Net Income | -$5 | -$484 | -$25 | $19 |
| % Margin | -1.3% | -116.5% | -6.6% | 4.4% |
| EPS Diluted | -0.07 | -6.33 | -0.33 | 0.25 |
| % Growth | 98.9% | -1,818.2% | -232% | – |
| Operating Cash Flow | $41 | $9 | -$11 | $51 |
| Capital Expenditures | -$15 | -$20 | -$29 | -$40 |
| Free Cash Flow | $26 | -$11 | -$40 | $11 |